1: In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem. T Fukuoka, S Ohya, Y Utsui, H Domon, T Takenouchi, T Koga, N Masuda, H Kawada, M Kakuta, M Kubota, C Ishii, C Ishii, E Sakagawa, T Harasaki, A Hirasawa, T Abe, H Yasuda, M Iwata, S Kuwahara Antimicrob Agents Chemother. 1997 Dec; 41(12): 2652–2663. PMCID: PMC164185
2: Safety and pharmacokinetics of CS-834, a new oral carbapenem antibiotic, in healthy volunteers. K Umemura, Y Ikeda, K Kondo, M Nakashima, H Naganuma, M Hisaoka, H Nishino, M Tajima Antimicrob Agents Chemother. 1997 Dec; 41(12): 2664–2669. PMCID: PMC164186
3: In Vitro and In Vivo Antibacterial Activities of CS-834, a New Oral Carbapenem Keizo Yamaguchi, Haruki Domon, Shuichi Miyazaki, Kazuhiro Tateda, Akira Ohno, Kazuhiro Ishii, Tetsuya Matsumoto, Nobuhiko Furuya
Antimicrob Agents Chemother. 1998 Mar; 42(3): 555–563. Correction in: Antimicrob Agents Chemother. 1998 Jun; 42(6): 1527. PMCID: PMC105498
4: Efficacy of CS-834 against Experimental Pneumonia Caused by Penicillin-Susceptible and -Resistant Streptococcus pneumoniae in Mice Takashi Fukuoka, Harumi Kawada, Akiko Kitayama, Tetsufumi Koga, Mikie Kubota, Tamako Harasaki, Yasuki Kamai, Satoshi Ohya, Hiroshi Yasuda, Masayuki Iwata, Shogo Kuwahara Antimicrob Agents Chemother. 1998 Jan; 42(1): 23–27. PMCID: PMC105450
5: Hypersusceptibility of the Pseudomonas aeruginosa nfxB Mutant to β-Lactams Due to Reduced Expression of the AmpC β-Lactamase Nobuhisa Masuda, Eiko Sakagawa, Satoshi Ohya, Naomasa Gotoh, Takeshi Nishino
Antimicrob Agents Chemother. 2001 Apr; 45(4): 1284–1286. doi: 10.1128/AAC.45.4.1284-1286.2001 PMCID: PMC90457